Back to trial detailsIntake questionnaire
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Applying to VA Ann Arbor Healthcare System, Ann Arbor, MI · Ann Arbor, Michigan
Answer a few short questions to share with the research team.
0 of 3 answered